Arousal Cream

Arousal Cream is a compounded topical formulation prepared by a 503A pharmacy that combines four pharmacologically active ingredients: aminophylline, ergoloid mesylates (ergoloid), pentoxifylline, and sildenafil. Each ingredient contributes a distinct mechanism to the formulation's overall action. Aminophylline, a xanthine derivative, inhibits phosphodiesterase and has vasodilatory properties. Ergoloid mesylates have historically been used for their vasodilatory and alpha-adrenergic effects. Pentoxifylline is a methylxanthine that improves microvascular blood flow by enhancing red blood cell deformability and reducing blood viscosity. Topical sildenafil, a PDE5 inhibitor, promotes smooth muscle relaxation and increased local blood flow in erectile and clitoral tissue through the nitric oxide/cGMP pathway.

The cream is applied topically to the external genital area, typically 15 to 30 minutes before anticipated sexual activity. Because it is applied locally rather than taken systemically, the pharmacokinetic profile differs meaningfully from oral or injectable formulations of these compounds -- systemic absorption of topical sildenafil, for instance, is substantially lower than with oral administration. Dosing instructions are individualized by the prescribing provider and included with your prescription.

Compounded multi-ingredient topical formulations for sexual dysfunction have been explored in clinical and provider practice settings, particularly where single-agent oral therapies have not been sufficient or are contraindicated. The combination of vasodilatory and PDE5-inhibitory mechanisms in a topical vehicle is intended to support localized engorgement and sensitivity. Effects, if experienced, are typically localized and onset may be observed within 20 to 30 minutes of application.

This formulation may be appropriate for individuals -- of any sex -- who have discussed localized arousal concerns with a licensed provider and for whom topical therapy is indicated. It may be considered when systemic agents are not preferred, or as part of a broader treatment approach. As with all treatments dispensed through FormBlends, this cream is prescribed only after a licensed provider reviews your online visit.

Because topical sildenafil is included, the formulation carries relevant safety considerations related to nitrate co-administration -- concurrent use of organic nitrates (including nitrate medications for heart conditions) is contraindicated. Individuals with hypersensitivity to any component should not use this product. Skin irritation at the application site is possible. Your provider will review your health history and current medications to confirm appropriateness before prescribing.